LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.

Hulgan, Todd / Donahue, John P / Hawkins, Charlene / Unutmaz, Derya / D'Aquila, Richard T / Raffanti, Stephen / Nicotera, Fred / Rebeiro, Peter / Erdem, Husamettin / Rueff, Melissa / Haas, David W

Journal of acquired immune deficiency syndromes (1999)

2003  Volume 34, Issue 2, Page(s) 119–126

Abstract: Objectives: P-glycoprotein (P-gp) may reduce antiretroviral efficacy by decreasing disposition of HIV-1 protease inhibitors into tissues and cells. In contrast, P-gp overexpression in vitro can inhibit HIV-1 replication, and some drugs induce P-gp ... ...

Abstract Objectives: P-glycoprotein (P-gp) may reduce antiretroviral efficacy by decreasing disposition of HIV-1 protease inhibitors into tissues and cells. In contrast, P-gp overexpression in vitro can inhibit HIV-1 replication, and some drugs induce P-gp expression. To explore which of these mechanisms predominate in vivo, this study characterized relationships between T-cell P-gp activity and clinical parameters in HIV-infected adults.
Methods: P-gp activity was quantified in total and naive CD4+ and CD8+ T cells of HIV-infected adults by flow cytometry using the substrate dye DiOC2(3). Demographic, virologic, immunologic, and treatment factors were obtained from medical records. Factors associated with P-gp activity were identified using multivariate linear regression.
Results: A total of 185 subjects (22% female; 34% African American) were studied, of whom 131 (71%) were receiving antiretroviral treatment. There was marked interindividual variability in P-gp activity. By multivariate analysis, higher CD4+ T-cell P-gp activity was associated with lower log10 HIV-1 RNA (P = 0.005), but not treatment or demographic factors. P-gp activity was correlated across T-cell subsets.
Conclusions: The inverse relationship between P-gp activity and plasma HIV-1 RNA is most consistent with an inhibitory effect on viral replication rather than drug disposition. Antiretroviral drug class did not independently predict P-gp activity.
MeSH term(s) ATP Binding Cassette Transporter, Subfamily B, Member 1/blood ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Acquired Immunodeficiency Syndrome/drug therapy ; Acquired Immunodeficiency Syndrome/immunology ; Adult ; CD4 Lymphocyte Count ; Drug Resistance, Viral ; Female ; HIV-1 ; Humans ; Male ; Middle Aged ; Polymorphism, Genetic ; RNA, Viral/blood ; T-Lymphocytes/chemistry
Chemical Substances ATP Binding Cassette Transporter, Subfamily B, Member 1 ; RNA, Viral
Language English
Publishing date 2003-10-02
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
ZDB-ID 645053-2
ISSN 1944-7884 ; 1077-9450 ; 1525-4135 ; 0897-5965 ; 0894-9255
ISSN (online) 1944-7884 ; 1077-9450
ISSN 1525-4135 ; 0897-5965 ; 0894-9255
DOI 10.1097/00126334-200310010-00001
Shelf mark
Zs.A 2442: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top